The Primary Care Companion to The Journal of Clinical Psychiatry is pleased to offer our readers supplemental information on an important area of clinical practice—premenstrual dysphoric disorder (PMDD). Premenstrual mood symptoms are a common complaint among women in our practices and, as always, an accurate assessment of symptoms, family history, longitudinal course, and treatment response is crucial for robust treatment outcomes. This is especially true for premenstrual dysphorias, in which the first step is to differentiate true PMDD from premenstrual symptomatic deteriorations often seen in other mood disorders.
This supplement features contributions from leaders in the field of PMDD research. In the first article, Jean Endicott, Ph.D., presents an overview of the history of the diagnosis of PMDD and describes the current diagnostic criteria of PMDD and those that differentiate PMDD from other illnesses. Dr. Ling then discusses recognition and treatment strategies. Drs. Steiner and Pearlstein detail the serotonergic foundations of PMDD and its currently approved treatment. The supplement concludes with a timely discussion of potential non-antidepressant strategies for the treatment of PMDD.
Enjoy this outstanding overview of the state of the art!
J. Sloan Manning, M.D.
Editor in Chief
The Primary Care Companion to the Journal of Clinical Psychiatry